| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
NYSE : PFE New York, New York, United States website |
Life Science | 63,627 | 64 | 45 | 19 |
|
|
Acorda Therapeutics
Public Pearl River, New York, United States website |
Life Science | 118 | 6 | 4 | 2 |
|
|
Axsome
NASDAQ : AXSM New York, New York, United States website |
Life Science | 386 | 2 | 2 | - |
|
|
AXM Pharma
Public New York, New York, United States website |
Life Science | 2 | 2 | 2 | - |
|
|
Enzo
NYSE : ENZ Farmingdale, New York, United States website |
Life Science | 32 | 2 | 2 | - |
|
|
Tonix Pharmaceuticals
NASDAQ : TNXP Chatham, New York, United States website |
Life Science | 8 | 2 | 2 | - |
|
|
Regeneron Pharmaceuticals
NASDAQ : REGN Tarrytown, New York, United States website |
Life Science | 14,202 | 2 | 2 | - |
|
|
ProPhase Labs
NASDAQ : PRPH Garden City, New York, United States website |
Life Science | 7 | 3 | 2 | 1 |
|
|
MindMed
NASDAQ : MNMD Vancouver, New York, United States website |
Life Science | - | 2 | 2 | - |
|
|
Applied DNA Sciences
NASDAQ : APDN Stony Brook, New York, United States website |
Life Science | 3 | 1 | 1 | - |
|
|
Tourmaline Bio
NASDAQ : TRML New York, New York, United States website |
Life Science | 45 | 1 | 1 | - |
|
|
Nuvation Bio
NYSE : NUVB New York, New York, United States website |
Life Science | 8 | 1 | 1 | - |
|
|
Scopus BioPharma
Public New York, New York, United States website |
Life Science | 12 | 1 | 1 | - |
|
|
Q/C Technologies
NASDAQ : QCLS New York, New York, United States website |
Life Science | - | 1 | 1 | - |
|
|
Firefly Neuroscience
NASDAQ : AIFF Buffalo, New York, United States website |
Life Science | - | 1 | 1 | - |
|
|
SELLAS Life Sciences Group
NASDAQ : SLS New York, New York, United States website |
Life Science | 1 | 1 | 1 | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.